Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

SARS-CoV-2 genomic characterization and clinical manifestation of the COVID-19 outbreak in Uruguay

medRxiv(2020)10.1101/2020.10.08.20208546Source: DataRank Database

SARS-CoV-2 genomic characterization and clinical manifestation of the COVID-19 outbreak in Uruguay is a research paper published in medRxiv (2020). On theSindex it has a DataRank of 0. It has been cited 6 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access6 citations

Download PDF

Cite:

Linked data & code

refseq

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)OA: greenTopics (74)IDs (PubMed, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (25)

Gordon W. Harkins ORCID,Batsirai Mabvakure ORCID,Sabine Smidt,Paul Zappile,Christian Marier

Live enrichment

PubMed:33052352 OpenAlex:https://openalex.org/W3092258615

National Institutes of Health

Grant: 5P30CA016087-32

Experimental Pathology

National Institutes of Health

Grant: 5R35GM119703-04

Genomic organization of long-distance gene regulation

National Institutes of Health

Grant: 6R01AI122953-05

Novel HIV-1 Env trimer probes for efficient isolation of broadly neutralizing antibodies

greenLicense: cc-by-nc-nd

repositoryhttps://www.medrxiv.org/content/medrxiv/early/2020/10/11/2020.10.08.20208546.1.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1101/2020.10.08.20208546

repositoryhttps://doi.org/10.1101/2020.10.08.20208546

repositoryhttps://pubmed.ncbi.nlm.nih.gov/33052352

Fields of Study

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesSARS-CoV-2 detection and testing0303 health sciences03 medical and health sciences

Keywords

OutbreakCohortTransmission (telecommunications)PandemicCladePublic healthMiddle East respiratory syndromeVirologyDominance (genetics)MedicineBiologyDiseaseCoronavirus disease 2019 (COVID-19)DemographyInfectious disease (medical specialty)PhylogeneticsGeneticsGeneInternal medicinePathologyMaleEpidemiologyCoronaviruses4202 EpidemiologyInfectious and parasitic diseasesRC109-216PharmacologieDisease OutbreaksDrug DiscoveryImmunologiePathologie maladies infectieusesMAXIMUM-LIKELIHOODPhylogenyclinical correlationsAged, 80 and overParasitologieGeneral MedicineEpidémiologieMiddle AgedQR1-502Microbiologie et protistologie [entomologie,phytoparasitolog.]Infectious Diseasesfull genome amplicon sequencingFemalephylogeographic BEAST analysisLife Sciences & Biomedicine0605 MicrobiologyMicrobiologie et protistologie [parasitologie hum. et anim.]AdultCOVID-19 outbreakAdolescentImmunologyMicrobiologyPolymorphism, Single NucleotideArticleYoung Adultspike D614G genetic mutationHumansAgedScience & TechnologySARS-CoV-23202 Clinical sciencesCOVID-19South America3107 MicrobiologyMutationUruguayParasitologyMicrobiologie et protistologie [bacteriol.virolog.mycolog.]

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being